![Christopher M. DeGiorgio](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher M. DeGiorgio
Corporate Officer/Principal chez NeuroSigma, Inc.
Postes actifs de Christopher M. DeGiorgio
Sociétés | Poste | Début | Fin |
---|---|---|---|
NeuroSigma, Inc.
![]() NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | 10/04/2012 | - |
Historique de carrière de Christopher M. DeGiorgio
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
NeuroSigma, Inc.
![]() NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | Health Technology |
- Bourse
- Insiders
- Christopher M. DeGiorgio
- Expérience